In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria   Ahlin Gustav   Bergström Christel   Svensson Richard   Palm Johan   Artursson Per  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

By Miners John O.   Mackenzie Peter I.   Knights Kathleen M.  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 196-208

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of the latest in vitro tools for drug metabolism studies

By Costa Ana   Sarmento Bruno   Seabra Vítor  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 1, 2014-01 ,pp. : 103-119

Informa Healthcare

Access to resources Recommend Favorite

PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex

By Jiang Yan-Yan   Tang Guo-Tao   Zhang Li-Hong   Kong Shu-Yi   Zhu Sai-Jie   Pei Yuan-Ying  

Journal of Drug Targeting, Vol. 18, Iss. 5, 2010-06 ,pp. : 389-403

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches

By Ito Kiyomi   Houston J. Brian  

Pharmaceutical Research, Vol. 22, Iss. 1, 2005-01 ,pp. : 103-112

Springer Publishing Company

Access to resources Recommend Favorite